BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29133193)

  • 21. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis.
    Wang F; Zhong S; Zhang H; Zhang W; Zhang H; Wu X; Chen B
    Dis Markers; 2015; 2015():482146. PubMed ID: 26063957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
    Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
    Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis.
    Fu X; Han Y; Wu Y; Zhu X; Lu X; Mao F; Wang X; He X; Zhao Y; Zhao Y
    Eur J Clin Invest; 2011 Nov; 41(11):1245-53. PubMed ID: 21521185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
    Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
    PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis.
    Lü L; Mao X; Shi P; He B; Xu K; Zhang S; Wang J
    Medicine (Baltimore); 2017 Jun; 96(22):e7085. PubMed ID: 28562579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of miR-21 in various cancers: an updating meta-analysis.
    Zhou X; Wang X; Huang Z; Wang J; Zhu W; Shu Y; Liu P
    PLoS One; 2014; 9(7):e102413. PubMed ID: 25019505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
    Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.
    Wang L; Yu J; Xu J; Zheng C; Li X; Du J
    Gene; 2015 Jan; 554(1):1-8. PubMed ID: 25452192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis.
    Shi M; Mu Y; Zhang H; Liu M; Wan J; Qin X; Li C
    Medicine (Baltimore); 2018 Aug; 97(32):e11505. PubMed ID: 30095616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of miR-222 in Various Cancers: a Systematic Review and Meta-Analysis.
    Wei T; Ye P; Peng X; Wu LL; Yu GY
    Clin Lab; 2016 Aug; 62(8):1387-1395. PubMed ID: 28164621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.
    Huang D; Peng Y; Ma K; Deng X; Tang L; Jing D; Shao Z
    BMC Cancer; 2018 Nov; 18(1):1189. PubMed ID: 30497428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.
    Duan F; Wang K; Dai L; Zhao X; Feng Y; Song C; Cui S; Wang C
    Medicine (Baltimore); 2016 Sep; 95(37):e4773. PubMed ID: 27631228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the MicroRNA-29 family in multiple human cancers: A meta-analysis and systematic review.
    Qi Y; Huang Y; Pang L; Gu W; Wang N; Hu J; Cui X; Zhang J; Zhao J; Liu C; Zhang W; Zou H; Li F
    Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):441-454. PubMed ID: 28063172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to explain the contradiction of microRNA 200c expression and survival in solid tumors? A meta-analysis.
    Wang HY; Shen J; Jiang CP; Liu BR
    Asian Pac J Cancer Prev; 2014; 15(8):3687-90. PubMed ID: 24870778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies.
    Yang J; Zhang JY; Chen J; Chen C; Song XM; Xu Y; Li J
    World J Surg Oncol; 2014 Aug; 12():254. PubMed ID: 25106061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of MicroRNA-125 in Various Human Malignant Neoplasms: a Meta-Analysis.
    Sun X; Zhang S; Ma X
    Clin Lab; 2015; 61(11):1667-74. PubMed ID: 26731991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
    Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
    Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.